NeuroVive takes a 10% stake in partner Isomerase

Damian Garde

Swedish drug developer  Pharmaceutical is cozying up to R&D Therapeutics, buying a in the company as the two move together on a CNS project.


FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS